Pavillon

Primary residential program: Pavillon's program philosophy is one of ensuring cessation of illicit use of substances with addiction potential (rather than reduced or moderated use), and is rooted in the evidence-based clinical practice of 12 step facilitation. We prescribe medications on an individualized basis as determined by our medical staff for substance use disorders as well as psychiatric conditions. Clinical programming includes additional evidence-based practices, such as: gender-specific care, cognitive-behavioral therapy, motivational interviewing, person-centered counseling, experiential therapies, trauma-informed therapies (e.g. Emdr), and options such as acupuncture and massage. Improvements experienced in the primary program progresses through the following three (3) stages. In terms of neurobiology and physiology, it is common for someone to experience cognitive clearing. After their substance use or drinking has stopped and while their cognition is clearing, their physiology is also continuing to adapt to the absence of substances. During this stag the person is gaining an ability to learn from the treatment program, as they participate, depending on the person's use pattern and the specific substances they were taking prior to admission. Initial feelings of denial, anger, blaming, grief and sadness can be present. During the second stage of persons stay, they begins to develop important insights. They begin to see that there is another way for them to live. The person works on their recovery needs with other people and begins to realize there are other people just like them. This raises hope. The person also begins to see what has happened as a result of their substance use. They begin to realize what they have done and what it has caused. They begin to process this with others, and doing so is a powerfully positive experience. In the final stage of our program, important changes continue to take place. In terms of neurobiology and physiology, the person is stable and continuing to improve. They begin to gain insight into what tools they will need to implement for lasting recovery following their treatment. They begin to identify the practical ways they will need to implement those tools for recovery. They gain significant insights about solutions that might be outside of themselves, and begin to integrate how those outside solutions can help and actually work to support recovery. In the final stage they also plan for the feelings and circumstances related to returning to their relationships, home, work, school, and life with others, including their family members and other important supportive people. This process of recovery planning and continuing care planning is vital. For fiscal year ending in 2024, Pavillon received with 1,190 inquiries regarding our treatment program, resulting in 361 admissions, 12,429 patient days, and an average length of stay of 36 days. We completed 63 professional 4-day evaluations.

Intensive outpatient program (iop): our organization provides a virtual intensive outpatient program (iop) for substance use disorders and this can include people with a co-occurring psychiatric conditions. The iop can serve as the primary treatment for those needing to begin care or as a step-down next level of care from a residential program including programs other than provided by Pavillon. The iop is offered in 3 groups per week in a daytime track or an evening track. Following iop we offer a step-down level of care twice per week in the same tracks. We also offer a once-per-week step down level of care following the twice-per-week level. Pavillon provides a 12 month long weekly group therapy on an outpatient basis that specifically focuses on those people with chronic relapse histories and needing to address the underlying dynamics leading to return to use. Individual sessions and psychiatric medication management can be provided for people receiving our outpatient care, if and as needed. Further, we provide an outpatient one day assessment determining the presence or absence of a substance use disorder, if such an extended evaluation method is needed. For fiscal year ending in 2024, we completed a total of 1,865 iop sessions, 813 group therapy sessions, 257 relapse prevention sessions, 1,233 individual and medication management office visits and 83 professional and non-professional assessments.

Extended care program: patients may individualize their length of stay after primary treatment, and continue in our extended care program if and as needed. Indicators for adding the extended care phase of treatment include matters of clinical complexity such as psychiatric conditions, previous treatment episodes for substance use disorders, previous time in recovery from substance use disorders, adverse factors during their upbringing in their family of origin, current family system dynamics, and personality factors that might serve as barriers to personal recovery. That program specializes in relapse prevention therapy with a focus on navigating underlying core issues in the context of their current life experience that can contribute to the relapse process.during fiscal year ending in 2024, our extended care program admitted 43 patients resulting in 2,455 patient days and an average length of stay of 49 days.